You just read:

Dipexium Announces Top-line Data from OneStep Phase 3 Trials with Locilex® in Mild Diabetic Foot Infection Did Not Meet Primary Clinical Endpoint of Superiority Versus Vehicle Plus Standardized Wound Care

News provided by

Dipexium Pharmaceuticals, Inc.

Oct 25, 2016, 07:00 ET